期刊文献+

社区高血压病患者治疗依从性与脑损害关系的研究 被引量:3

The research and countermeasure between the therapy compliance on hypertension patients in community and its brain relationship damaged
下载PDF
导出
摘要 目的:了解社区高血压病患者治疗不同依从性下与脑损害发生的关系,为高血压防治提供依据。方法:收集我院随访的高血压病患者治疗不同依从性情况及发生脑卒中(脑出血、脑梗死)的情况。结果:高血压治疗依从性好组发生脑卒中的概率低于治疗依从性低组。结论:为了减少高血压病患者脑卒中的发生,应提高患者治疗的依从性。 Objective: To explore the relationship between different therapy compliances and the brain damage on the community hypertension patients. Methods: The different compliances information of the follow-up survey hypertention patients to our hospital and the information of occuring cerebral apoplexy (cerebral hemorrhage, cerebral infarction) of these patients were colleted and analyzed. Results: The probability of occuring cerebral apoplexy in the team which had good therapy compliance on hypertension was far more below the team which had the bad one. Conclusion: The therapy compliance should be improved in order to reduce the cerebral apoplexy occuring on the hypertension patients.
出处 《华夏医学》 CAS 2006年第3期433-434,共2页 Acta Medicinae Sinica
关键词 高血压病 治疗依从性 脑卒中 hypertension therapy compliance cerebral apoplexy
  • 相关文献

参考文献5

  • 1BITTAR N.Maintaining long-term control of blood pressure:the role improved compliance[J].Clin Cardiol,1995,18(Suppl.Ⅲ):Ⅲ12.
  • 2彭绩,周华,罗炳锐,杨汝培,程景泉,李耀培,洪旺全,周俊安.深圳特区常住人口高血压病流行特征研究[J].医学与社会,1999,12(6):6-8. 被引量:2
  • 3MORISKY D E,GREEN L W,LEVINE D M.Concurrent and predictive validity of a self-reported measure of medication adherence[J].Med Care,1986,24(1):67.
  • 4MAR J,RODRIGUEZ-ARTALEJO F.Which is more important for the efficiency of hypertension treatment:hypertension stage,type of drug or therapeutic compliance[J].J Hypertens,2001,19:149-155.
  • 5任涛,李立明,吴明,戴立强.高血压社区综合防治的成本效果分析[J].中国慢性病预防与控制,2001,9(4):173-175. 被引量:48

二级参考文献9

  • 1[1]Wilhelmsen L,Berglund G,Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden[J]. European Heart Journal, 1986,7∶279-288.
  • 2[2]Jacobs DR, Lupker RV, Mittelmark MB, et al. Community-wide prevention strategies. Evaluation design of the Minnesota Heart Health Progran[J]. J Chronic Dis, 1986,39∶775-788.
  • 3[3]WHO European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-yera result [J]. Lancet, 1986,1∶869-872.
  • 4[4]The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High blood Pressure (JNC V) [J]. Arch Intern Med, 1993, 153(1)∶154-183.
  • 5[5]Mac Mahon S, Podgers A. Blood pressure, antihypertensive treatment and stroke risk[J]. J Hypertens, 1994,12(10)∶S5-14.
  • 6[6]Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia [J]. Lancet, 1998, 352(9143)∶1801-1807.
  • 7[7]Ambrosioni E, Bacchelli S.Clinical approach to the hypertensive patient. New guidelines[J]. Ann Ital Med Int, 1998,13(1)∶30-36.
  • 8[8]Quan A, Kerlikowske K, Gureyffier F, et al. Efficacy of treating hypertension in women[J]. J Gen Intern Med, 1999, 14(12)∶718-729.
  • 9吴锡桂.我国高血压、冠心病的流行现况与展望[J].中国慢性病预防与控制,1998,6(2):52-53. 被引量:103

共引文献48

同被引文献12

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部